Loading stock data...

Trident Lifeline Limited

BSE: TLL

BSE
302.90 0.15 (0.05%)

Prev Close

302.75

Open Price

301

Volume

5,400

Today Low / High

297 / 303

52 WK Low / High

222 / 331.95

Range

288 - 318

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 302.9, reflecting a change of 0.15 (0.04954583%). The expected target range on the BSE is 288 - 318. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

07 Oct 301.00 0.63%
06 Oct 303.00 -0.08%
03 Oct 296.00 0.68%
01 Oct 284.35 4.62%
30 Sep 294.00 -0.77%
29 Sep 293.00 -2.01%
26 Sep 293.00 1.02%
25 Sep 288.00 1.74%
24 Sep 291.00 -0.26%
23 Sep 288.00 3.37%
22 Sep 282.00 0.00%
19 Sep 290.00 0.00%
18 Sep 290.00 -0.69%
17 Sep 283.00 -1.06%
16 Sep 282.50 0.18%
15 Sep 282.00 -1.77%
12 Sep 280.05 1.27%
11 Sep 290.00 0.29%
10 Sep 280.80 0.00%
09 Sep 297.50 -5.61%

Trident Lifeline Limited Graph

Trident Lifeline Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Trident Lifeline Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 302.90, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 302.90 305.93 275.34 - 336.52
308.96 247.17 - 370.75
311.99 218.39 - 405.58
Bearish Scenario 302.90 299.87 269.88 - 329.86
296.84 237.47 - 356.21
293.81 205.67 - 381.96

Overview of Trident Lifeline Limited

ISIN

INE0MKA01014

Industry

Medical - Pharmaceuticals

Vol.Avg

8,862

Market Cap

3,511,277,380

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for TLL

Metric Value Recommendation
Overall Rating C Sell
DCF Score 1 Strong Sell
ROE Score 4 Buy
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 86.96 Cr 68.16 Cr 41.41 Cr 0.4762 0.45 Cr 0.00 Cr 9.37 Cr 11.75 Cr 10.22 23.09 Cr 0.1351
2024-03-31 44.63 Cr 32.07 Cr 12.56 Cr 0.2814 0.04 Cr 0.75 Cr 8.07 Cr 6.34 Cr 5.52 10.27 Cr 0.1421
2023-03-31 31.69 Cr 22.58 Cr 9.12 Cr 0.2876 0.02 Cr 0.54 Cr 6.19 Cr 6.02 Cr 6.23 7.41 Cr 0.1898
2022-03-31 21.77 Cr 18.17 Cr 3.60 Cr 0.1654 0.02 Cr 0.67 Cr 2.58 Cr 3.95 Cr 6.92 3.31 Cr 0.1814
2021-03-31 9.62 Cr 7.63 Cr 1.99 Cr 0.2070 0.00 Cr 0.30 Cr 1.11 Cr 0.63 Cr 0.55 1.41 Cr 0.0657

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.46 Cr 156.01 Cr 86.36 Cr 64.4564 Cr 54.03 Cr 51.57 Cr 28.24 Cr 36.52 Cr 0.00 Cr 0.00 Cr 10.72 Cr 53.5547 Cr
2024-03-31 6.65 Cr 87.08 Cr 33.13 Cr 52.8965 Cr 18.41 Cr 11.76 Cr 12.58 Cr 20.37 Cr 4.31 Cr 0.00 Cr 3.77 Cr 20.2562 Cr
2023-03-31 13.78 Cr 62.57 Cr 15.46 Cr 45.6350 Cr 7.69 Cr -6.09 Cr 7.17 Cr 5.35 Cr 1.19 Cr 0.00 Cr 3.34 Cr 11.5340 Cr
2022-03-31 0.16 Cr 13.83 Cr 9.06 Cr 4.7757 Cr 2.45 Cr 2.30 Cr 3.71 Cr 0.31 Cr 0.35 Cr 0.00 Cr 0.00 Cr 7.5698 Cr
2021-03-31 0.09 Cr 11.44 Cr 11.91 Cr -0.4707 Cr 4.53 Cr 4.43 Cr 5.30 Cr 0.37 Cr 0.00 Cr 0.00 Cr 0.00 Cr 7.3372 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -10.2417 Cr -13.8247 Cr 19.7605 Cr -22.6992 Cr -4.1938 Cr 2.4605 Cr 0.0000 Cr 0.0000 Cr 23.6577 Cr 0.0000 Cr -7.8385 Cr
2024-03-31 3.0771 Cr -21.8201 Cr 11.6126 Cr -14.8141 Cr -7.1250 Cr 6.6543 Cr -17.8912 Cr 6.3439 Cr 10.6177 Cr 0.0000 Cr -5.4157 Cr
2023-03-31 -18.7109 Cr -10.4421 Cr 42.7487 Cr -25.6349 Cr 13.6228 Cr 13.7793 Cr -6.9240 Cr 6.5825 Cr 5.9868 Cr 0.0000 Cr -3.4563 Cr
2022-03-31 -0.3405 Cr -0.4452 Cr 0.9277 Cr -0.7957 Cr 0.1420 Cr 0.1566 Cr -0.4552 Cr 2.9836 Cr -2.6673 Cr 0.0000 Cr 1.5594 Cr
2021-03-31 1.4846 Cr -0.5563 Cr -0.9584 Cr 0.5235 Cr -0.0303 Cr 0.0935 Cr -0.5577 Cr 0.8539 Cr -1.9370 Cr 0.0000 Cr -4.3350 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 23.61 Cr 10.95 Cr 12.66 Cr 0.5363 3.71 Cr 3.06 Cr 2.66 6.52 Cr 0.1297
2025-03-31 46.05 Cr 38.82 Cr 7.22 Cr 0.1568 -0.29 Cr 3.82 Cr 3.33 10.02 Cr 0.0830
2024-12-31 11.83 Cr 3.72 Cr 8.10 Cr 0.6852 3.47 Cr 2.79 Cr 2.42 4.64 Cr 0.2357
2024-09-30 15.45 Cr 7.92 Cr 7.53 Cr 0.4873 3.89 Cr 3.09 Cr 2.69 4.59 Cr 0.2003
2024-06-30 13.15 Cr 9.34 Cr 3.81 Cr 0.2896 1.95 Cr 2.29 Cr 1.99 3.65 Cr 0.1743

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 2.46 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -69.65 Cr
2025-03-31 2.46 Cr 0.00 Cr 2.46 Cr 27.68 Cr 28.24 Cr 90.37 Cr 36.52 Cr 156.01 Cr 86.36 Cr
2024-12-31 0.00 Cr 0.00 Cr 6.57 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -57.62 Cr
2024-09-30 6.57 Cr 0.00 Cr 6.57 Cr 19.83 Cr 13.02 Cr 61.33 Cr 21.24 Cr 97.86 Cr 40.24 Cr
2024-06-30 0.00 Cr 0.00 Cr 6.65 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -53.95 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 2.78 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 3.82 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 2.79 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 3.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹749.80 ₹89,783,824,011.00 ₹47,767.00

Key Executives

MD & Executive Director
Mr. Shravan Harikrishna Patel

Gender: male

Year Born: 1994

Chief Financial Officer
Mr. Ashish Anandsingh Bafna

Gender: male

Year Born:

Executive Chairman
Mr. Hardik Jigishkumar Desai

Gender: male

Year Born: 1978

Whole-Time Director
Ms. Rupaben Chetankumar Jariwala

Gender: female

Year Born:

Company Secretary
Ms. Nikita Sharma

Gender: female

Year Born:

FAQs about Trident Lifeline Limited

Who is the CEO of the company?

The CEO is Hardik Jigishkumar Desai.

What is the current market price of the stock?

The current price is ₹302.90.

What is the 52-week price range?

The range is ₹222-331.95.

What is the market capitalization of the company?

The market capitalization is ₹351.13 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 27.32.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Trident Lifeline Limited (ISIN: INE0MKA01014) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹351.13 crores and an average daily volume of 8,862 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.